4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95+%, 5g

1-Ethoxy-2-nitro-4-(trifluoromethyl)benzene, 95.0%, 5g

(S)-5-(8,9,10,11,12,13,14,15-Octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-5H-dibenzo[b,f]azepine, 98%, 100mg

1-[(4R)-4-Phenyl-2-thioxo-3-oxazolidinyl]-1-propanone, 97%, 1g

3,5-DIBROMO-2,4,6-TRIMETHYLPYRIDINE HCL, 95.0%, 1g

6,7-Dimethoxy-3,4-dihydroisoquinoline Hydrochloride>98.0%(HPLC)(T)5g

1-(2-Pyrazinyl)-piperazine, 98.0%, 10g

methyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate, 97%, 250mg

1H-imidazo[4,5-b]pyrazin-2-amine, 98%, 50mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-iodobenzyl)pyrrolidine-2-carboxylic acid, 97%, 1g

C-(4-Trifluoromethyl-cyclohexyl)-methylamine, 97.0%, 5g

3-BROMO-7-AZAINDOLE-4-CARBOXYLIC ACID, 95.0%, 5g

4-Bromobenzoylacetonitrile, 96.0%, 5g